Multidose Drug Dispensing in Community Healthcare Settings for Patients With Multimorbidity and Polypharmacy
INQUIRY: The Journal of Health Care Organization, Provision, and Financing · 2024
DOI: 10.1177/00469580241274268 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift INQUIRY: The Journal of Health Care Organization, Provision, and Financing, 2024. Verfasst von Adela Martín-Oliveros und 6 weiteren Autor:innen. Beteiligte Einrichtung: Spanish Society of Clinical, Family and Community Pharmacy (SEFAC), Madrid, Spain. Hauptthemen laut MEDLINE: Polypharmacy, Multimorbidity. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Medikationssicherheit
Abstract (Originalsprache)
Multidose drug dispensing (MDD) is the dispensing of different drugs in dose bags containing one, some, or all units of medicine that a patient needs to take at specific times. The aim of this narrative review is to provide an overview of the literature describing the use of MDD systems in community healthcare settings in patients with multimorbidity and polypharmacy. A literature search identified 14 studies examining adherence, medication knowledge, quality of drug prescription (including inappropriate drug use, drug-drug interactions), medication incidents, and drug changes after MDD initiation, as well as healthcare professional (HCP) and patient perspectives. There are limited data on MDD in community healthcare settings, particularly on outcomes such as adherence. Studies are mostly from Northern Europe. Patients selected for MDD are more likely to be older, female, cognitively impaired, and have a higher number of disease diagnoses and drugs than those who do not receive drugs through MDD. MDD is generally initiated for patients who have decreased capacity for medication management. Several advantages of MDD have been reported by patients and HCPs, and studies indicate that MDD can be improved by medication review, defining clear roles and responsibilities of HCPs in the medication management chain, and comprehensive follow-up of patients. Future development, implementation, and assessment of MDD systems in community healthcare should be designed in collaboration with HCPs and patients, to identify ways to optimize the systems and improve patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Spanish Society of Clinical, Family and Community Pharmacy (SEFAC), Madrid, Spain.
- Giovanni Lorenzini Medical Foundation, Milan, Italy.
- Viatris, Madrid, Spain.
- Viatris Group, Lörrach, Baden-Württemberg, Germany.
- Viatris, Vilnius, Lithuania.
- Viatris Inc., London, UK.
ORCID-Profile: Alessandro Monaco
Zitieren
APA
Martín-Oliveros, A., Plaza Zamora, J., Monaco, A., Anitua Iriarte, J., Schlageter, J., Ducinskiene, D., & Donde, S. (2024). Multidose Drug Dispensing in Community Healthcare Settings for Patients With Multimorbidity and Polypharmacy. INQUIRY: The Journal of Health Care Organization, Provision, and Financing. https://doi.org/10.1177/00469580241274268
Vancouver
Martín-Oliveros A, Plaza Zamora J, Monaco A, Anitua Iriarte J, Schlageter J, Ducinskiene D, et al. Multidose Drug Dispensing in Community Healthcare Settings for Patients With Multimorbidity and Polypharmacy. INQUIRY: The Journal of Health Care Organization, Provision, and Financing. 2024. doi:10.1177/00469580241274268
BibTeX
@article{MartnOliveros2024,
author = {Martín-Oliveros, Adela and Plaza Zamora, Javier and Monaco, Alessandro and Anitua Iriarte, Javier and Schlageter, Jessica and Ducinskiene, Danute and Donde, Shaantanu},
title = {Multidose Drug Dispensing in Community Healthcare Settings for Patients With Multimorbidity and Polypharmacy},
journal = {INQUIRY: The Journal of Health Care Organization, Provision, and Financing},
year = {2024},
doi = {10.1177/00469580241274268}
}
EUVIMED